151 related articles for article (PubMed ID: 27886416)
1. A Case of Solitary Well-Differentiated Papillary Mesothelioma with Invasive Foci in the Pleura.
Shimizu S; Yoon HE; Ito N; Tsuji T; Funakoshi Y; Utsumi T; Sakaguchi M; Tsujimura T; Kasai T; Hiroshima K; Matsumura A
Pathol Int; 2017 Jan; 67(1):45-49. PubMed ID: 27886416
[TBL] [Abstract][Full Text] [Related]
2. Well-differentiated papillary mesothelioma with invasion to the chest wall.
Torii I; Hashimoto M; Terada T; Kondo N; Fushimi H; Shimazu K; Takeda S; Takuwa T; Okumura Y; Sato A; Yamamoto T; Fukuoka K; Tanaka F; Nishigami T; Nakano T; Hasegawa S; Tsujimura T
Lung Cancer; 2010 Feb; 67(2):244-7. PubMed ID: 19880210
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological Characteristics of Well-differentiated Papillary Mesothelioma of The Peritoneum: A Single-institutional Experience of 12 Cases.
Kim M; Kim HS
In Vivo; 2019; 33(2):633-642. PubMed ID: 30804152
[TBL] [Abstract][Full Text] [Related]
4. Well-differentiated papillary mesothelioma of the pleura: a series of 24 cases.
Galateau-Sallé F; Vignaud JM; Burke L; Gibbs A; Brambilla E; Attanoos R; Goldberg M; Launoy G;
Am J Surg Pathol; 2004 Apr; 28(4):534-40. PubMed ID: 15087673
[TBL] [Abstract][Full Text] [Related]
5. Histological and immunohistochemical characteristics and
Fujishima F; Konosu-Fukaya S; Nabeshima K; McNamara KM; Sakamoto K; Sakurada J; Sasano H; Nakamura Y
Indian J Pathol Microbiol; 2021; 64(2):277-281. PubMed ID: 33851620
[TBL] [Abstract][Full Text] [Related]
6. Well-differentiated papillary mesothelioma with invasive foci.
Churg A; Allen T; Borczuk AC; Cagle PT; Galateau-Sallé F; Hwang H; Murer B; Murty VV; Ordonez N; Tazelaar HD; Wick M
Am J Surg Pathol; 2014 Jul; 38(7):990-8. PubMed ID: 24618613
[TBL] [Abstract][Full Text] [Related]
7. Well-differentiated papillary mesothelioma of the female peritoneum: a clinicopathologic study of 26 cases.
Malpica A; Sant'Ambrogio S; Deavers MT; Silva EG
Am J Surg Pathol; 2012 Jan; 36(1):117-27. PubMed ID: 22024662
[TBL] [Abstract][Full Text] [Related]
8. BAP1 loss is unusual in well-differentiated papillary mesothelioma and may predict development of malignant mesothelioma.
Lee HE; Molina JR; Sukov WR; Roden AC; Yi ES
Hum Pathol; 2018 Sep; 79():168-176. PubMed ID: 29763720
[TBL] [Abstract][Full Text] [Related]
9. Coalescent pleural malignant mesothelioma and adenocarcinoma of the lung, involving only minor asbestos exposure.
Tsuzuki T; Ninomiya H; Natori Y; Ishikawa Y
Pathol Int; 2008 Jul; 58(7):451-5. PubMed ID: 18577116
[TBL] [Abstract][Full Text] [Related]
10. Synchronous occurrence of pulmonary adenocarcinoma and pleural diffuse malignant mesothelioma.
Imenpour H; Ivaldi GP; Brianti A; Pastorino G; Biggi S; Auriati L; Simonassi C
Pathologica; 2013 Dec; 105(6):353-6. PubMed ID: 24730341
[TBL] [Abstract][Full Text] [Related]
11. [A comparative evaluation of immunohistochemical markers for the differential diagnosis between malignant mesothelioma, non-small cell carcinoma involving the pleura, and benign reactive mesothelial cell proliferation].
Szczepulska-Wójcik E; Langfort R; Roszkowski-Sliz K
Pneumonol Alergol Pol; 2007; 75(1):57-69. PubMed ID: 17541913
[TBL] [Abstract][Full Text] [Related]
12. Localized mesothelioma tumour arising synchronously with a primary contralateral lung cancer.
Andrews W; Paul S; Narula N; Altorki NK
Interact Cardiovasc Thorac Surg; 2013 Dec; 17(6):1061-2. PubMed ID: 23956266
[TBL] [Abstract][Full Text] [Related]
13. Well-differentiated papillary mesothelioma: a clinicopathological and immunohistochemical study of 18 cases with additional observation.
Chen X; Sheng W; Wang J
Histopathology; 2013 Apr; 62(5):805-13. PubMed ID: 23530588
[TBL] [Abstract][Full Text] [Related]
14. Collagenous Spherulosis in Well-Differentiated Papillary Mesothelioma in a Female With Multilocular Peritoneal Inclusion Cysts.
AbdullGaffar B; Raman LG
Int J Surg Pathol; 2019 Jun; 27(4):427-431. PubMed ID: 30522362
[TBL] [Abstract][Full Text] [Related]
15. Malignant transformation of well-differentiated papillary mesothelioma 13 years after the diagnosis: a case report.
Costanzo L; Scarlata S; Perrone G; Rossi L; Papa A; Di Matteo FM; Tonini G; Onetti Muda A; Antonelli-Incalzi R; Tomao S
Clin Respir J; 2014 Jan; 8(1):124-9. PubMed ID: 24118858
[TBL] [Abstract][Full Text] [Related]
16. Loss of BAP1 Expression in Atypical Mesothelial Proliferations Helps to Predict Malignant Mesothelioma.
Pillappa R; Maleszewski JJ; Sukov WR; Bedroske PP; Greipp PT; Boland JM; Yi ES; Peikert T; Aubry MC; Roden AC
Am J Surg Pathol; 2018 Feb; 42(2):256-263. PubMed ID: 29076876
[TBL] [Abstract][Full Text] [Related]
17. Well-Differentiated Papillary Mesothelial Tumor: An Unusual Radiologic Presentation: A Case Report.
Abdelghafar M; Anand K; Paiva-Correia A; Smith EP; Salle FG; Joshi V
J Chest Surg; 2023 May; 56(3):220-223. PubMed ID: 37131285
[TBL] [Abstract][Full Text] [Related]
18. A rare tumoral combination, synchronous lung adenocarcinoma and mantle cell lymphoma of the pleura.
Hatzibougias D; Bobos M; Karayannopoulou G; Karkavelas G; Karapanagiotidis GT; Foroulis CN; Kostopoulos I
World J Surg Oncol; 2008 Dec; 6():137. PubMed ID: 19114021
[TBL] [Abstract][Full Text] [Related]
19. Malignant mesothelioma in situ.
Churg A; Hwang H; Tan L; Qing G; Taher A; Tong A; Bilawich AM; Dacic S
Histopathology; 2018 May; 72(6):1033-1038. PubMed ID: 29350783
[TBL] [Abstract][Full Text] [Related]
20. The 2015 World Health Organization Classification of Tumors of the Pleura: Advances since the 2004 Classification.
Galateau-Salle F; Churg A; Roggli V; Travis WD;
J Thorac Oncol; 2016 Feb; 11(2):142-54. PubMed ID: 26811225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
